Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference

Core Viewpoint - Beta Bionics, Inc. is set to present at TD Cowen's 46th Annual Health Care Conference on March 4, 2026, highlighting its advancements in diabetes management solutions [1]. Company Overview - Beta Bionics, Inc. is a commercial-stage medical device company focused on designing, developing, and commercializing innovative solutions for insulin-requiring individuals with diabetes [3]. - The company utilizes advanced adaptive closed-loop algorithms to enhance the treatment of diabetes, aiming to improve health and quality of life for patients [3]. - The iLet Bionic Pancreas is noted as the first FDA-cleared insulin delivery device that autonomously determines insulin doses, potentially improving outcomes for a wide range of diabetes patients [3]. Investor Relations - The company provides a live audio webcast of its presentations, which can be accessed on its website under the "Investors—Events & Presentations" section [2]. - Contact information for investor relations and media inquiries is available, with Blake Beber as the Head of Investor Relations and Karen Hynes as the Vice President of Marketing [4].